Rankings
▼
Calendar
TECX FY 2024 Earnings — Tectonic Therapeutic, Inc. Revenue & Financial Results | Market Cap Arena
TECX
Tectonic Therapeutic, Inc.
$635M
FY 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$58M
Net Income
-$58M
EPS (Diluted)
$-3.93
Cash Flow
Operating Cash Flow
-$59M
Free Cash Flow
-$59M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$153M
Total Liabilities
$12M
Stockholders' Equity
$141M
Cash & Equivalents
$141M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$58M
-$45M
-29.9%
Net Income
-$58M
-$43M
-35.4%
← Q4 2023
All Quarters
Q1 2024 →